logo-loader
GKN

Melrose Industries says GKN turnaround 'on track' in first half

The interim dividend was lifted 10% to 1.7p per share

GKN -

Melrose Industries PLC (LON:MRO) said the three main divisions of GKN remain on track to meet targets, with Aerospace accelerating to offset headwinds affecting the automotive sector.

Nearly a year and a half after completing the hostile takeover of engineer GKN, the turnaround group generated £6.0bn of adjusted revenue in the six months to 30 June, double that of a year ago, while statutory revenue was also doubled to £5.7bn.

Statutory losses narrowed to £128mln from £372mln.

Adjusted operating profit was £539mln, which takes account of £550mln of adjusting items of which £79mln are cash. For the full year, analysts expect around £1.08bn-£1.09bn

Stronger cash generation led to leverage coming in better than expected, with debt at 2.3 times underlying earnings (EBITDA), and the interim dividend was lifted 10% to 1.7p per share.

Looking to improve

Referring to the group's 'buy, improve, sell' maxim, chairman Justin Dowley said: “These results show the initial fruits of the 'improve' stage of Melrose's ownership of GKN and, with the overall GKN margin increasing positively, we are excited about what is possible.”

This year Melrose has invested in Aerospace technology and continued with operational improvements in this business, seeing organic growth of 7% for the half and operating profit up 37%.

While the Driveline business remained largely weak in line with wider auto industry trends, Dowley hailed the "substantial" development of the eDrive electric vehicle powertrain.

Asia, including a Chinese joint venture, remains a difficult area for this business, with sales down 17% to drag Melrose's Autos arm down 7% vs the market at 5% with Asia down 17%.

After the "very good performance" in Aerospace, analysts at UBS said they do not expect full-year consensus forecasts to change "but investors should be reassured post the 1H delivery".

Indeed, shares were up 7% to 198.4p at Thursday lunchtime.

--Add broker comment--

Quick facts: GKN

Price: £0.00

Market: LSE
Market Cap: £0.00
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: VolitionRx achieves 'massive breakthrough' in its Nu.Q...

VolitionRx Limited (NYSEAMERICAN:VNRX) CEO Cameron Reynolds tells Proactive the cancer diagnostic company has achieved a 'massive breakthrough' in the development of its Nu.Q Capture cancer-detection technology, which is the ability to enrich nucleosomes. Reynolds says enriching nucleosomes...

6 hours, 49 minutes ago

2 min read